Essentra (FLRAF)
(Delayed Data from OTC)
$2.15 USD
0.00 (0.00%)
Updated Aug 2, 2024 10:56 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Essentra falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 393 | 418 | 1,320 | 1,151 | 1,244 |
Cost Of Goods | NA | 432 | 1,251 | 1,123 | 1,142 |
Gross Profit | NA | -14 | 68 | 28 | 102 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | -14 | 68 | 28 | 102 |
Non-Operating Income | NA | 9 | 4 | 2 | 3 |
Interest Expense | NA | 31 | 27 | 23 | 21 |
Pretax Income | NA | -36 | 46 | 8 | 84 |
Income Taxes | NA | 2 | 7 | 0 | 31 |
Minority Interest | NA | 5 | 2 | 2 | 4 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 7 | -38 | 39 | 8 | 53 |
Extras & Discontinued Operations | -1 | -189 | 0 | 0 | 0 |
Net Income (GAAP) | 7 | -233 | 37 | 6 | 49 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 59 | 170 | 124 | 192 |
Depreciation & Amortization (Cash Flow) | NA | 73 | 101 | 96 | 90 |
Income After Depreciation & Amortization | 0 | -14 | 68 | 28 | 102 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 297.00 | 303.10 | 302.30 | 274.70 | 265.60 |
Diluted EPS Before Non-Recurring Items | 0.13 | 0.02 | 0.25 | 0.17 | 0.27 |
Diluted Net EPS (GAAP) | 0.02 | -0.77 | 0.12 | 0.02 | 0.19 |
Fiscal Year end for Essentra falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |